
Sign up to save your podcasts
Or
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
4.4
3030 ratings
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
17 Listeners
15 Listeners
63 Listeners
12 Listeners
73 Listeners
0 Listeners
6 Listeners
316 Listeners
42 Listeners
110 Listeners
54 Listeners
124 Listeners
43 Listeners
27 Listeners
54 Listeners
84 Listeners
166 Listeners